Among the tumors reported in DM BRCA2 families, the most frequent was BC, with a percentage of 76.2%, followed by bBC, male breast cancer (MBC), CC, pancreatic cancer (PAC), and LEU with a percentage of 4.8% (Figure 6). This evidence concerns the gene BRCA2 and familial pancreatic carcinoma.